Prolactin Decreases LPS-induced Inflammatory Cytokines by Inhibiting TLR-4/NFκB Signaling in the Human Placenta

Overview

Journal Mol Hum Reprod

Specialties Molecular Biology
Reproductive Medicine

Date 2019 Jul 3

PMID 31263869

Citations 22

Authors

A Olmos-Ortiz

M Deciga-Garcia

E Preciado-Martinez

L Bermejo-Martinez

P Flores-Espinosa

I Mancilla-Herrera

C Irles

A C Helguera-Repetto

B Quesada-Reyna

V Goffin

L Diaz

V Zaga-Clavellina

Affiliations

Soon will be listed here.

Abstract

Prolactin (PRL) plays an important role in trophoblast growth, placental angiogenesis and immunomodulation within the feto-maternal interface, where different cell types secrete PRL and express its receptor. During pregnancy, inflammatory signalling is a deleterious event that has been associated with poor fetal outcomes. The placenta is highly responsive to the inflammatory stimulus; however, the actions of PRL in placental immunity and inflammation remain largely unknown. The aim of this study was to evaluate PRL effects on the TLR4/NFkB signalling cascade and associated inflammatory targets in cultured explants from healthy term human placentas. An in utero inflammatory scenario was mimicked using lipopolysaccharides (LPS) from Escherichia coli. PRL significantly reduced LPS-dependent TNF-α, IL-1β and IL-6 secretion and intracellular levels. Mechanistically, PRL prevented LPS-mediated upregulation of TLR-4 expression and NFκB phosphorylation. In conclusion, PRL limited inflammatory responses to LPS in the human placenta, suggesting that this hormone could be critical in inhibiting exacerbated immune responses to infections that could threaten pregnancy outcome. This is the first evidence of a mechanism for anti-inflammatory activity of PRL in the human placenta, acting as a negative regulator of TLR-4/NFkB signaling.

Citing Articles

Elevated levels of exogenous prolactin promote inflammation at the maternal-fetal interface via the JAK2/STAT5B signaling axis.

Williams A, Hossack D, Thompson N, Sim Y, Wilson C, Schuch V Front Immunol. 2025; 15:1496610.

PMID: 39763651 PMC: 11701216. DOI: 10.3389/fimmu.2024.1496610.

Prolactin Role in COVID-19 and Its Association with the Underlying Inflammatory Response.

Polyzou E, Schinas G, Bountouris P, Georgakopoulou D, de Lastic A, Parthymou A Int J Mol Sci. 2024; 25(22).

PMID: 39595974 PMC: 11593808. DOI: 10.3390/ijms252211905.

IMPACT OF REAL-LIFE ENVIRONMENTAL EXPOSURES ON REPRODUCTION: Systemic and ovarian impacts of heat stress in the porcine model.

Keating A, Ross J, Baumgard L Reproduction. 2024; 168(6.

PMID: 39401133 PMC: 11623122. DOI: 10.1530/REP-24-0217.

Dissecting the Impact of Maternal Androgen Exposure on Developmental Programming through Targeting the Androgen Receptor.

Lu H, Jiang H, Li C, Derisoud E, Zhao A, Eriksson G Adv Sci (Weinh). 2024; 11(36):e2309429.

PMID: 39075722 PMC: 11423211. DOI: 10.1002/advs.202309429.

Culture of Human Fetal Membranes in a Two Independent Compartment Model: An Ex Vivo Approach.

Flores-Espinosa P, Mancilla-Herrera I, Olmos-Ortiz A, Diaz L, Zaga-Clavellina V Methods Mol Biol. 2024; 2781:61-69.

PMID: 38502443 DOI: 10.1007/978-1-0716-3746-3_6.

References

Jikihara H, Handwerger S . Tumor necrosis factor-alpha inhibits the synthesis and release of human decidual prolactin. Endocrinology. 1994; 134(1):353-7. DOI: 10.1210/endo.134.1.8275950. View

Gibori G, Richards J . Dissociation of two distinct luteotropic effects of prolactin: regulation of luteinizing hormone-receptor content and progesterone secretion during pregnancy. Endocrinology. 1978; 102(3):767-74. DOI: 10.1210/endo-102-3-767. View

Garzia E, Clauser R, Persani L, Borgato S, Bulfamante G, Avagliano L . Prolactin and proinflammatory cytokine expression at the fetomaternal interface in first trimester miscarriage. Fertil Steril. 2013; 100(1):108-15.e1-2. DOI: 10.1016/j.fertnstert.2013.02.053. View

Dautt-Leyva J, Canizalez-Roman A, Acosta Alfaro L, Gonzalez-Ibarra F, Murillo-Llanes J . Maternal and perinatal complications in pregnant women with urinary tract infection caused by Escherichia coli. J Obstet Gynaecol Res. 2018; 44(8):1384-1390. DOI: 10.1111/jog.13687. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Goffin V, Norman M, Martial J . Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity. Mol Endocrinol. 1992; 6(9):1381-92. DOI: 10.1210/mend.6.9.1435787. View

Schagger H . Tricine-SDS-PAGE. Nat Protoc. 2007; 1(1):16-22. DOI: 10.1038/nprot.2006.4. View

Ferriani R, Silva de Sa M . Prolactin levels in blood from the intervillous space of the human placenta. Gynecol Obstet Invest. 1988; 26(1):73-6. DOI: 10.1159/000293676. View

Flores-Espinosa P, Preciado-Martinez E, Mejia-Salvador A, Sedano-Gonzalez G, Bermejo-Martinez L, Parra-Covarruvias A . Selective immuno-modulatory effect of prolactin upon pro-inflammatory response in human fetal membranes. J Reprod Immunol. 2017; 123:58-64. DOI: 10.1016/j.jri.2017.09.004. View

10.

Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno A . Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2017; 46(5):465-488. DOI: 10.1515/jpm-2017-0027. View

11.

Featherstone K, White M, Davis J . The prolactin gene: a paradigm of tissue-specific gene regulation with complex temporal transcription dynamics. J Neuroendocrinol. 2012; 24(7):977-90. PMC: 3505372. DOI: 10.1111/j.1365-2826.2012.02310.x. View

12.

Mitchell S, Vargas J, Hoffmann A . Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med. 2016; 8(3):227-41. PMC: 8363188. DOI: 10.1002/wsbm.1331. View

13.

Napso T, Yong H, Lopez-Tello J, Sferruzzi-Perri A . The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation. Front Physiol. 2018; 9:1091. PMC: 6108594. DOI: 10.3389/fphys.2018.01091. View

14.

Takser L, Mergler D, de Grosbois S, Smargiassi A, Lafond J . Blood manganese content at birth and cord serum prolactin levels. Neurotoxicol Teratol. 2004; 26(6):811-5. DOI: 10.1016/j.ntt.2004.07.001. View

15.

Olmos-Ortiz A, Garcia-Quiroz J, Avila E, Caldino-Soto F, Halhali A, Larrea F . Lipopolysaccharide and cAMP modify placental calcitriol biosynthesis reducing antimicrobial peptides gene expression. Am J Reprod Immunol. 2018; 79(6):e12841. DOI: 10.1111/aji.12841. View

16.

Beijar E, Mallard C, Powell T . Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta. 2005; 27(2-3):322-6. DOI: 10.1016/j.placenta.2004.12.012. View

17.

Sodhi A, Tripathi A . Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: involvement of p-38 MAP kinase, STAT3 and NF-kappaB. Cytokine. 2008; 41(2):162-73. DOI: 10.1016/j.cyto.2007.11.007. View

18.

Bao L, Tessier C, Prigent-Tessier A, Li F, Buzzio O, Callegari E . Decidual prolactin silences the expression of genes detrimental to pregnancy. Endocrinology. 2007; 148(5):2326-34. DOI: 10.1210/en.2006-1643. View

19.

Stefanoska I, Jovanovic Krivokuca M, Vasilijic S, Cujic D, Vicovac L . Prolactin stimulates cell migration and invasion by human trophoblast in vitro. Placenta. 2013; 34(9):775-83. DOI: 10.1016/j.placenta.2013.06.305. View

20.

Zaga-Clavellina V, Parra-Covarrubias A, Ramirez-Peredo J, Vega-Sanchez R, Vadillo-Ortega F . The potential role of prolactin as a modulator of the secretion of proinflammatory mediators in chorioamniotic membranes in term human gestation. Am J Obstet Gynecol. 2014; 211(1):48.e1-6. DOI: 10.1016/j.ajog.2014.01.039. View